![A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies - ScienceDirect A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379123000538-gr1.jpg)
A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies - ScienceDirect
![DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing - eBioMedicine DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing - eBioMedicine](https://www.thelancet.com/cms/attachment/51040dec-7564-4d79-98f2-3a94bca23b7c/gr3_lrg.jpg)
DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing - eBioMedicine
Are Dutch people willing to speak Dutch to foreigners who start a conversation in Dutch, but not yet fluently? I'm considering to learn Dutch before I go to the Netherlands. - Quora
![DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing - eBioMedicine DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing - eBioMedicine](https://www.thelancet.com/cms/attachment/1b290fce-50a4-4d87-a1f1-9d69193f8eeb/gr1_lrg.jpg)